Fidelity Investments’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Fidelity Investments's INMB Position: Q3 2026 in Review
Fidelity Investments reduced its INmune Bio (INMB) stake by 0.19% in Q3 2026, selling an estimated $134 and leaving 33,624 shares worth $65.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4228.
Fidelity Investments first reported a position in INMB in Q4 2022 and has held it in 16 quarters since. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- Fidelity Investments held 33,624 shares of INmune Bio worth $65.6K as of Q3 2026.
- Fidelity Investments sold 65 INmune Bio shares in Q3 2026, an estimated $134.
- INmune Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #4228 holding.
- Fidelity Investments first reported a position in INmune Bio in Q4 2022 and has held it in 16 quarters since.
- 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.